NetworkNewsBreaks

WednesdaySep 23, 2026 9:00 am

NetworkNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Reports Annual and Special Meeting Results, Legal Name Change Effective Oct. 1

This article has been disseminated on behalf of Helus Pharma and may include paid advertising. Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) announced voting results from its annual and special meeting of shareholders held Sept. 22, 2026, with 46,452,598 common shares represented, or 63.58% of outstanding shares as of the record date. Shareholders appointed Zeifmans LLP as auditor, approved setting the board at eight directors and elected Theresa Firestone, Grant Froese, Paul Glavine, Michael Halstead, Eric Hoskins, Mark Lawson, Freda Lewis-Hall and Eric So as directors. Shareholders also approved changing the company’s legal name from Cybin Inc. to Helus Pharma…

Continue Reading

TuesdaySep 22, 2026 12:28 pm

NetworkNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Applauds Signing of U.S.-Denmark-Greenland Security Agreement 

Greenland Mines (NASDAQ: GRML) applauded the formal signing at the United Nations General Assembly of a new security agreement among the United States, the Kingdom of Denmark and Greenland. The company said the agreement formalizes the framework announced Friday and marks a milestone in strengthening long-term Arctic and North Atlantic security while underscoring Greenland growing strategic importance to the United States and Western alliance. Greenland Mines said its Sarfartoq and Skaergaard projects are positioned to support critical-minerals supply for the United States, Europe and other Western allies. Sarfartoq Initial Assessment includes a high-case pretax net present value of approximately $2.05…

Continue Reading

TuesdaySep 22, 2026 12:06 pm

NetworkNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Featured in AINewsWire Editorial on AI Data Center Energy Demand 

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.  MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announced its placement in an AINewsWire ("AINW") editorial examining the growing electricity demands of artificial intelligence data centers and the potential for next-generation facilities to be located closer to abundant primary energy sources. The editorial highlights natural hydrogen as AI infrastructure growth increases demand for reliable energy. MAX Power Mining is advancing what it describes as Canada’s first confirmed subsurface natural hydrogen system at the Lawson Discovery in south-central Saskatchewan. The company is moving through…

Continue Reading

TuesdaySep 22, 2026 11:56 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured in AINewsWire Editorial on Growing Wafer Inspection Market 

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, announced its placement in an AINewsWire ("AINW") editorial examining growth in the wafer inspection market amid increasing demand for advanced semiconductor packaging to support artificial intelligence infrastructure. The editorial highlights mounting pressure on the automation and inspection technologies supporting packaging lines as manufacturers work to increase production capacity, yield and speed. Nightfood Holdings recently announced the formation of TechForce Advanced Manufacturing Inc., a majority-owned subsidiary established with a Taiwan-based manufacturing partner to expand production of automated Wafer Sorter and automated optical inspection ("AOI") systems for 8-inch and 12-inch wafers. The company…

Continue Reading

TuesdaySep 22, 2026 11:47 am

NetworkNewsBreaks – American Fusion Inc. (OTC: AMFN) Expands Texatron Patent Portfolio, Advances Testing and Potential Uplisting

American Fusion (OTC: AMFN), a developer of advanced fusion-energy technology, provided a corporate update highlighting the filing of 21 additional U.S. patent applications, bringing its intellectual property portfolio to 151 pending U.S. patent applications. The company continues testing and engineering validation of its Texatron(TM) Fusion Engine(TM) and has identified a site for a dedicated testing facility, negotiated principal terms and a purchase price and expects to enter escrow on the property through its affiliate. American Fusion (OTCQB: AMFN) is also advancing preparations for a potential uplisting to a national securities exchange, with the Texas Stock Exchange ("TXSE") under evaluation as…

Continue Reading

TuesdaySep 22, 2026 10:20 am

NetworkNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Featured in MiningNewsWire Editorial on Expanding Rare Earth Supply Chains

Greenland Mines (NASDAQ: GRML) is featured in a MiningNewsWire editorial examining growing demand for rare earth elements and efforts to establish more diversified Western critical-mineral supply chains. The editorial highlights Greenland Mines application for a new license covering approximately 262 square kilometers immediately east of its existing Sarfartoq license, which, if granted, would increase its footprint from approximately 192 square kilometers to approximately 454 square kilometers. The company is advancing the Sarfartoq Rare Earth Magnet District, including the neodymium- and praseodymium-enriched ST1 deposit, while pursuing a district-scale exploration strategy. Greenland Mines is featured alongside MP Materials (NYSE: MP), USA Rare…

Continue Reading

TuesdaySep 22, 2026 10:10 am

NetworkNewsBreaks – Roth Capital Partners to Host 5th Annual Healthcare Opportunities Conference Sept. 29 in New York

Roth Capital Partners will host its 5th Annual Healthcare Opportunities Conference on Sept. 29, 2026, at the Metropolitan Club in New York City, bringing together C-suite executives from more than 30 public healthcare companies and leading institutional investors. The invitation-only event will feature one-on-one and small-group meetings with companies representing biotechnology, life science tools and diagnostics and medical technology. ROTH Capital Partners said the conference will also feature discussions covering neuroscience, drug pricing and coverage, regulatory uncertainty and capital constraints in biotechnology and minimal residual disease ("MRD") monitoring in solid tumors. The event will be hosted by ROTH senior healthcare…

Continue Reading

TuesdaySep 22, 2026 10:00 am

NetworkNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Launches Rate Optimization Program Offering $3,000 Lender Credit

Beeline Holdings (NASDAQ: BLNE) announced the launch of its Rate Optimization Program, offering a $3,000 lender credit on qualifying Bank Statement purchase and refinance mortgages of at least $250,000 locked by Oct. 31, 2026. The credit can be applied toward eligible closing costs, used to buy down the borrower interest rate or applied toward future mortgage payments, subject to applicable loan terms and requirements. The program is designed to accelerate growth of Beeline Bank Statement mortgage business while reducing costs for self-employed and non-traditional income borrowers. Beeline shifted its mortgage strategy toward Non-Qualified Mortgage ("Non-QM") products in May 2026, primarily…

Continue Reading

TuesdaySep 22, 2026 9:40 am

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Confirms Sept. 30 Expiration of Outstanding Warrants

Nutriband (NASDAQ: NTRB) confirmed that its outstanding warrants will expire as scheduled Sept. 30, 2026, at 5 p.m. EDT, with no extension or repricing. Warrant holders may exercise at the current strike price of $6.43 per share until expiration, after which unexercised warrants will expire in their entirety and be removed from the NTRBW Nasdaq listing. Nutriband currently has 910,904 warrants outstanding, representing approximately $5.86 million in potential proceeds to the company if all warrants are exercised at the $6.43 strike price. To view the full press release, visit https://nnw.fm/5DRKN About Nutriband Inc. We are primarily engaged in the development of…

Continue Reading

TuesdaySep 22, 2026 9:30 am

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Receives USPTO Notice of Allowance for LP-284 Blood Cancer Treatment Patent

Lantern Pharma (NASDAQ: LTRN), an AI-driven precision oncology company, announced that the United States Patent and Trademark Office ("USPTO") issued a Notice of Allowance for U.S. Patent Application No. 18/500,032, covering methods of using LP-284 to treat mantle cell lymphoma ("MCL"), double-hit lymphoma ("DHL") and other blood cancers. The allowed claims include LP-284 as a monotherapy and in combination with several classes of anti-cancer agents. Once issued, the patent is expected to extend LP-284 intellectual property protection into 2042, adding method-of-use protection to Lantern existing composition-of-matter patent estate. Lantern Pharma (NASDAQ: LTRN) is evaluating LP-284 in an ongoing Phase 1a…

Continue Reading